These studies are still running in the background but are no longer recruiting patients, or are in follow up.
- Diamond Study –
This is a study for patients with type 2 diabetes to identify whether they can reverse their diabetes by following a very low calorie eating regime. Some surgeries have patients following the study dietary plan and others follow their usual care route.
- HipDys –
Evaluation of an aid to diagnosis for congenital dysplasia of the hip in General Practice.
For more information about the study please click here
- Attack –
This study seeks to find out if low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD).
- Alternative CErvical screening (ACES) in Primary Care study
Manchester University were running this study to determine whether a urine test can accurately be used for cervical screening in the future.
For more information please visit the study website by following this link.
https://sites.manchester.ac.uk/aces/
The SAFER Trial –
Screening for Atrial Fibrillation with ECG to Reduce stroke
Queen Square Medical Practice took part in the SAFER Trial, a research trial about screening for atrial fibrillation (irregular heartbeat) to reduce the risk of stroke.
Researchers at the University of Cambridge want to find out if a national screening programme for atrial fibrillation:
- is possible
- will prevent strokes
- is good value for money
Eligible patients aged 70 years and over received an invitation letter from us in the post. A total of 370 patients from the practice consented to take part in the trial.
Participants were randomly allocated into one of two groups: control or screening. Those in the screening group were invited to screen for atrial fibrillation at home using a hand-held ECG monitor, 4 times a day over 3 weeks (see ECG device below).
The trial has now completed recruitment and is in the long-term follow-up phase, collecting outcome data via relevant electronic health records until 2028.
A word from the SAFER research team:
“Thank you to everyone who consented to join the SAFER trial – we are very grateful for your valuable contribution in helping us to answer our research question.
Final trial results will be available in late 2028. In the meantime, updates on the SAFER trial will be posted to our website www.safer.phpc.cam.ac.uk.”
